Department of Cardiology, Chi Mei Medical Center, 71004, Tainan, Taiwan.
Department of Public Health, College of Medicine, National Cheng Kung University, 70101, Tainan, Taiwan.
Rev Cardiovasc Med. 2020 Dec 30;21(4):577-581. doi: 10.31083/j.rcm.2020.04.140.
The pandemic of coronavirus disease 2019 (COVID-19) caused by the newly discovered virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had been noticed to have high morbidity and mortality. Apart from pneumonia, COVID-19 can also cause damage to the cardiovascular system, and co-occurring with cardiovascular injury leads to a poorer prognosis. Besides, amid the pandemic of COVID-19, the management of critical cardiovascular events needs to further account for the highly infectious coronavirus, prompt and optimal treatments, clinician's safety, and healthcare provider's capacity. This review article aims to provide more comprehensive and appropriate guidance for the management of critical cardiovascular disease, including ST-segment elevation myocardial infarction (STEMI), non-STEMI acute coronary syndrome, cardiogenic shock, acute heart failure, cardiopulmonary resuscitation, and advanced care planning, during the COVID-19 epidemic.
由新型冠状病毒 SARS-CoV-2 引起的 2019 年冠状病毒病（COVID-19）大流行，其发病率和死亡率都很高。除了肺炎，COVID-19 还会对心血管系统造成损害，与心血管损伤同时发生会导致预后更差。此外，在 COVID-19 大流行期间，严重心血管事件的管理还需要进一步考虑高度传染性的冠状病毒、及时和最佳的治疗、临床医生的安全以及医疗保健提供者的能力。本文旨在为 COVID-19 流行期间严重心血管疾病的管理，包括 ST 段抬高型心肌梗死（STEMI）、非 ST 段抬高型急性冠状动脉综合征、心源性休克、急性心力衰竭、心肺复苏和高级医疗计划，提供更全面和适当的指导。
